A rare disease, as defined by the European Union, is one that affects fewer than 5 persons per 10000, predominantly children. These conditions often lack effective treatments and are considered orphan diseases. Despite their rarity, there are numerous rare diseases, sharing origin and common underlying molecular mechanisms. Focusing on the metabolic rare disease cblC, we demonstrate how an approach based on biophysical methods, can pave the way for exploring novel treatment avenues for such conditions.

Studying an orphan disease by a biophysical approach: The case of cblC

Vilasi S.
;
Longo L.;Randazzo L.;Bollati M.;Carrotta R.;Costa M. A.;De Rosa M.;Mangione M. R.;Martorana V.;Milani M.;Passantino R.
2024

Abstract

A rare disease, as defined by the European Union, is one that affects fewer than 5 persons per 10000, predominantly children. These conditions often lack effective treatments and are considered orphan diseases. Despite their rarity, there are numerous rare diseases, sharing origin and common underlying molecular mechanisms. Focusing on the metabolic rare disease cblC, we demonstrate how an approach based on biophysical methods, can pave the way for exploring novel treatment avenues for such conditions.
2024
Istituto di Biofisica - IBF
Methylmalonic aciduria and homocystinuria
rare diseases
MMACHC
cblC
AdoCbl, MeCbl, CNCbl, OHCbl
File in questo prodotto:
File Dimensione Formato  
ncc13106.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 307.87 kB
Formato Adobe PDF
307.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/536902
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact